Kyntra Bio, Inc. KYNB
Set alert
4.57 USD 0.00 0.00%
As of Nov 2, 10:23 AM ET
4.57 Day range 4.63
4.32 52-week range 11.39
- YTD
- -47.95%
- 1 year
- -58.90%
- Open
- 4.63
- Prev close
- 4.57
- Mkt cap
- 18.50M
- Vol
- 1.68K
- Avg vol
- 21.68K
- EPS
- -7.64
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.57
- High
- 4.63
2Y chart
Signals (102)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 13, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 17, 2026 | 1 month ago |
| SMA: Bearish | Sep 17, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 11, 2026 | 1 month ago |
| RSI: Overbought | Sep 2, 2026 | 2 months ago |
| RSI: Overbought | Aug 25, 2026 | 2 months ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 19, 2026 | 2 months ago |
| SMA: Bearish | Aug 13, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 7, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
| SMA: Bearish | Jul 24, 2026 | 3 months ago |
| SMA: Bullish | Jul 21, 2026 | 3 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 15, 2026 | 3 months ago |
| SMA: Bullish | Jun 26, 2026 | 4 months ago |
| SMA: Bearish | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | Jun 12, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 12, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 2, 2026 | 5 months ago |
| MACD: Buy Signal | May 27, 2026 | 5 months ago |
| SMA: Bearish | May 13, 2026 | 5 months ago |
| SMA: Bullish | May 12, 2026 | 5 months ago |
| SMA: Bearish | May 8, 2026 | 5 months ago |
| MACD: Sell Signal | May 8, 2026 | 5 months ago |
| SMA: Bullish | Apr 30, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 30, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 28, 2026 | 6 months ago |
| SMA: Bearish | Apr 23, 2026 | 6 months ago |
| SMA: Bullish | Apr 22, 2026 | 6 months ago |
| SMA: Bearish | Apr 21, 2026 | 6 months ago |
| SMA: Bullish | Apr 17, 2026 | 6 months ago |
| SMA: Bearish | Apr 15, 2026 | 6 months ago |
| SMA: Bullish | Apr 14, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 1, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 26, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 9, 2026 | 7 months ago |
| MACD: Sell Signal | Feb 25, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 20, 2026 | 8 months ago |
| SMA: Bearish | Jan 23, 2026 | 9 months ago |
| SMA: Bearish | Jan 23, 2026 | 9 months ago |
| SMA: Bullish | Jan 22, 2026 | 9 months ago |
| SMA: Bullish | Jan 22, 2026 | 9 months ago |
| SMA: Bearish | Jan 20, 2026 | 9 months ago |
| SMA: Bearish | Jan 20, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 20, 2026 | 9 months ago |
| SMA: Bullish | Jan 13, 2026 | 9 months ago |
| SMA: Bearish | Jan 12, 2026 | 9 months ago |
| SMA: Bullish | Jan 7, 2026 | 9 months ago |
| SMA: Bullish | Jan 2, 2026 | 10 months ago |
| SMA: Bearish | Dec 29, 2025 | 10 months ago |
| SMA: Bullish | Dec 26, 2025 | 10 months ago |
| SMA: Bearish | Dec 17, 2025 | 10 months ago |
| SMA: Bearish | Dec 16, 2025 | 10 months ago |
| SMA: Bullish | Dec 15, 2025 | 10 months ago |
| SMA: Bullish | Dec 15, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 5, 2025 | 11 months ago |
| RSI: Oversold | Dec 2, 2025 | 11 months ago |
| SMA: Bearish | Nov 12, 2025 | 11 months ago |
| RSI: Oversold | Nov 12, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 11, 2025 | 11 months ago |
| MACD: Buy Signal | Oct 31, 2025 | 1 year ago |
| SMA: Bearish | Oct 15, 2025 | 1 year ago |
| SMA: Bullish | Oct 13, 2025 | 1 year ago |
| SMA: Bearish | Oct 10, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 8, 2025 | 1 year ago |
| RSI: Overbought | Aug 29, 2025 | 1 year ago |
| RSI: Overbought | Aug 21, 2025 | 1 year ago |
| RSI: Overbought | Aug 18, 2025 | 1 year ago |
| RSI: Overbought | Aug 12, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 7, 2025 | 1 year ago |
| SMA: Bullish | Aug 4, 2025 | 1 year ago |
| SMA: Bearish | Jul 31, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 30, 2025 | 1 year ago |
| SMA: Bullish | Jul 10, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 8, 2025 | 1 year ago |
| RSI: Oversold | Jun 17, 2025 | 1 year ago |
| SMA: Bearish | Jun 13, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 13, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 9, 2025 | 1 year ago |
| SMA: Bullish | Jun 6, 2025 | 1 year ago |
| SMA: Bearish | May 30, 2025 | 1 year ago |
| MACD: Sell Signal | May 30, 2025 | 1 year ago |
| SMA: Bullish | May 20, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 11, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 18, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 17, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 26, 2025 | 1 year ago |
| SMA: Bearish | Feb 25, 2025 | 1 year ago |
| RSI: Overbought | Feb 20, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 14, 2025 | 1 year ago |
| SMA: Bullish | Feb 13, 2025 | 1 year ago |
| SMA: Bearish | Feb 11, 2025 | 1 year ago |
| SMA: Bullish | Feb 5, 2025 | 1 year ago |
| SMA: Bearish | Feb 4, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 16, 2025 | 1 year ago |
| RSI: Overbought | Jan 6, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 23, 2024 | 1 year ago |
| RSI: Overbought | Dec 23, 2024 | 1 year ago |
Financials — quick view
KYNB Revenue — quarterly -1.47M
KYNB Net income — quarterly 11.97M
KYNB EPS — quarterly 2.96
News
- Maxim Group Initiates Coverage On Kyntra Bio with Buy Rating, Announces Price Target of $35
- Immatics (NASDAQ:IMTX) vs. Kyntra Bio (NASDAQ:KYNB) Financial Contrast
- Kyntra Bio Appoints Andrew E. Singer, MBA to its Board of Directors
- Lake Street Initiates Coverage On Kyntra Bio with Buy Rating, Announces Price Target of $41
- Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference
- HC Wainwright & Co. Reiterates Buy on Kyntra Bio, Maintains $43 Price Target
- Kyntra Bio To Reduce The Maximum Aggregate Payments Under Its Royalty Financing Agreement From $125M To $65M; Co. Accelerated Payment Of $42.6M Upfront, Bringing Total Payments Made To Date To $50M; Remaining Payments, Capped At $15M, To Be Paid From 50% Of The Revenue Received From Astellas In The Astellas Territories Excluding Japan
- Kyntra Bio Continues Balance Sheet Transformation with Material Reduction of Royalty Financing Obligation
- Kyntra Bio, Inc. (KYNB) Q2 2026 Earnings Call Transcript
- Kyntra Bio (KYNB) Reports Q2 Loss, Lags Revenue Estimates
Your note
Sign in to keep a note on KYNB — it syncs with the Stock Master app.